Add Yahoo as a preferred source to see more of our stories on Google. Wegovy pens are sorted at a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little Dec ...
Market opportunities lie in the expansion of medical weight loss programs, rising demand for GLP-1 drugs, and increased roles for physicians and bariatricians in weight management. With declining ...
Weight loss pills could account for 25% of the market share over the long term. The GLP-1 market is expected to grow to $100 billion by 2030. New GLP-1 oral versions could receive FDA approval by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results